Array Biopharma Inc (ARRY): Array BioPharma's CEO Discusses F1Q 2014

Array Biopharma Inc (ARRY): Array BioPharma's CEO Discusses F1Q 2014

Filed under: drug treatment programs maryland

The Phase 1 trial of our wholly-owned hema product, ARRY-614, is close to completion as well and we look forward to getting more mature results for this trial by the end of 2013 and finalizing our next steps for this program. … You may recall that Dr …
Read more on Seeking Alpha

 

NIH funds UB HCV drug development, TB nanomedicine and

Filed under: drug treatment programs maryland

The UB PSL contributes to clinical pharmacology studies that investigate new drug treatments and designs and participates in drug interaction research during new drug development programs. The UB PSL operates a bioanalytical … of the prevalent co …
Read more on UB News Center

 

Monoclonal antibodies show promise as effective HIV therapy

Filed under: drug treatment programs maryland

Oct. 30, 2013 — A research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a group of recently discovered antibodies may be a highly effective therapy for the treatment of HIV. … HIV-specific …
Read more on Science Daily (press release)